Metagenomics Market Size, Share, Industry Trends Report, 2018-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Metagenomics Market


The global metagenomics market size was estimated at USD 409.26 million in 2017. Investments in development of bioinformatics platforms to support metagenomics and microbiome profiling is anticipated to drive the market. Growing interest of researchers in associated novel research areas such as metatranscriptomics, metaproteomics, and metabolomics has also encouraged microbiologists to explore associated workflows. 
Scope for usage has widened in recent years and diversity of ecosystems explored using metagenome analysis has increased by multiple folds over the recent past. Rapid advancements in genomic technologies and ancillary protocols have enabled the study of microbial consortia within the host as a combined entity. This is anticipated to hold significant market potential in various life sciences industries. Introduction of high-throughput sequencing technologies such as iSeq 100 System, MiniSeq System, abd NextSeq 550 System for amplicon sequencing has facilitated phylogeny and taxonomy studies of diverse metagenomics samples.
 
Bioinformatics companies play a significant role in the growth of metagenomic laboratories as they help support their workflows. For instance, in December 2018, QIAGEN launched metagenomic plugins for analysis in collaboration with CosmosID. Furthermore, De novo assembly, whole genome sequencing, shotgun metagenomics, and 16S rRNA sequencing allow simplified analysis. This increase in deployment of sequencing technologies can be attributed to declining cost in recent years. 
Innovative methodological and conceptual tools such as Integrated Microbial Genome/Microbiome (IMG/M) are employed to accelerate metagenomics related workflows, thereby boosting revenue generation. IMG/M is useful in analyzing the functional capability of microbial communities based on the metagenome sequence.
Furthermore, advancements in bioinformatics programming has enabled researchers to conduct 3D metagenomics experiments. For instance, in February 2017, a team of researchers at Institut Pasteur conducted an experiment using 3D structures of DNA fragments collected from microbiota of mouse intestine to analyze interactions between phage and bacteria.
As of August 2016, approximately 125,000 new viral genomes were discovered with a comprehensive metagenomics analysis of thousands of different samples. Increase in number of viral genes identified, coupled with rising concerns related to viral diseases such as Hepatitis B, Hepatitis C, virus induced diarrhea, influenza, condylomas, and HIV/AIDS, is anticipated to drive the development of novel metagenome study products for clinical use.

Market Segmentation, Outlook & Viewpoint: Global Metagenomics Market


Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Kits & Reagents

Sequencing & Data Analytics Services

Others


Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Sequencing Driven

Function Driven


Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Environmental

Human Health

Others


Key Players, Recent Developments & Regional Insights: Global Metagenomics Market


Metagenomics has been widely adopted in environmental applications. Ability to screen uncultured microbes, coupled with growing interest of microbiologists in microbes that inhabit extreme environments, has driven the segment. Environmental applications include use in the agriculture sector to support crop growth, bioremediation through wastewater treatment, clean-up of oil spills and gasoline leaks, and biofuel production by harnessing microbial power.
 
Introduction of advanced sequencing technologies has led to rapid increase in number of studies carried out for establishing a relation between microbes and human diseases. Research programs such as the American Human Microbiome Project and the European project MetaHIT (Metagenomics of Human Intestinal Tract) have aided in metagenome-based exploration of the human intestinal microbiome using reference gene catalogs. This, in turn, is fostering the growth of the human health segment. Increase in investment in similar studies related to human microbiome is also slated to benefit the segment.

Regional Insights
North America dominated the market in terms of revenue in 2017. This can be attributed to presence of a substantial number of prominent biotechnology companies, most of which are focused on development of metagenomics workflows. For instance, in May 2015, CosmosID introduced its GENIUS Metagenomics application available in Illumina’s BaseSpace Apps for use with NGS platforms.
Asia Pacific is expected to witness the fastest growth during the forecast period owing to constant developments undertaken to strengthen the bioinformatics infrastructure and genomic landscape in countries such as India and China. Significant variations in climate and environment across Asian countries is expected to positively influence the adoption of these methods in future.
Metagenomics Market Share Insights
Some of the prominent players operating in this market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup.
Companies are engaged in acquisition of emerging players to enhance their market presence and improve their strategic partnerships and collaborations with players in developing markets. For instance, in March 2016, Diversigen-microbiome analysis service provider, entered into a collaboration with South Korea-based bioanalytical CRO-BioCore Co. Ltd. to expand its operations in the APAC region.

Key Insights Covered: Global Metagenomics Market
1.  North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Metagenomics industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Metagenomics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Metagenomics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Metagenomics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Metagenomics industry.

Research Methodology: Global Metagenomics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other